Shares of Cannara Biotech (OTCMKTS:CNBTF – Get Free Report) were down 0.9% during trading on Thursday. The company traded as low as $1.4670 and last traded at $1.4670. Approximately 300 shares were traded during trading, a decline of 99% from the average daily volume of 33,127 shares. The stock had previously closed at $1.48.
Cannara Biotech Price Performance
The company’s 50 day moving average is $1.46 and its 200-day moving average is $1.34.
Cannara Biotech Inc is a Canadian cannabis company that cultivates, manufactures and distributes cannabis products for the adult-use and medical markets. The company operates from Quebec and focuses on producing indoor-grown cannabis in a controlled environment.
Cannara’s product portfolio includes dried flower, pre-rolls, vape products, concentrates and other cannabis formats. Its consumer brands include Tribal, Nugz and Orchid CBD, which are marketed through authorized provincial cannabis distribution systems and retailers.
The company’s operations are centered on its cultivation and processing facilities in Quebec, supporting sales primarily in Canadian markets where its products are authorized for distribution.
Read More
- Five stocks we like better than Cannara Biotech
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
